0QN1 fundamentals
SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) financial statements, including revenue, expenses, and profit
The total revenue of 0QN1 for the last semiannual is 25.00 M CHF, and it's 77.15% higher compared to the previous semiannual. The net income of H2 24 is -26.71 M CHF.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
TTM